AllovirÂ Inc (ALVR) Financials

$9.81

$0.15 (1.55%)

As on 18-Mar-2025 16:00EDT

Market cap

$49 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	--	--	--	--	--	0.17
Cost of Revenue	--	0.40	2.57	1.12	0.07	--
Gross Profit	--	-0.40	-2.57	-1.12	-0.07	0.17
Operating Expenses	65.44	180.93	171.20	169.82	71.31	26.87
Operating Profit (EBIT)	-65.44	-181.33	-171.20	-169.82	-71.31	-26.70
Other Income	--	--	2.23	-1.14	1.53	--
Profit before Tax	-58.77	-190.54	-168.98	-170.96	-69.78	-23.84
Provision for Tax	-58.77	-0.13	-0.27	1.01	-1.40	-2.07
Profit after Tax (Net Income)	-58.77	-190.42	-168.71	-171.96	-68.38	-21.77
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-168.71	-171.96	-69.78	-23.84

Liabilities ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	113.31	145.78	224.52	225.27	353.06	-51.50
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	16.65	28.22	23.48	5.46	181.82
Current Liabilities	5.24	28.37	24.34	37.85	12.29	9.11
Total Liabilities	118.55	190.80	277.08	286.59	370.82	139.42

Assets ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	--	3.16	34.03	33.25	9.50	12.11
Current Assets	118.55	187.64	243.05	253.35	361.32	127.31
Total Assets	118.55	190.80	277.08	286.59	370.82	139.42
Total Debt*	--	27.43	35.39	30.07	8.69	11.76
Net Current Assets	113.31	159.27	218.71	215.50	349.02	118.21

Cashflow ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	-67.71	-124.45	-142.05	-106.32	-60.81	-20.16
Cash Flow from Investing Activities	--	--	-80.48	185.98	-169.50	-64.64
Cash from Financing Activities	0.02	70.50	126.96	0.23	291.98	120.92
Net Cash Inflow / Outflow	--	--	-95.57	79.90	61.67	--

Financials Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	-41.02	-87.93	-65.49	-55.73	-42.47	61.89
ROE (%)	-45.37	-102.85	-75.02	-59.47	-45.35	53.03
ROA (%)	-38.00	-81.40	-59.86	-52.31	-26.80	-26.43
EBIT Margin (%)	--	--	--	--	--	-16,182.42
Net Margin (%)	--	--	-7,575.66	15,124.19	-4,484.00	-13,196.36
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	--	-1.00	-0.85
EBIT Growth (%)	--	-11.30	-0.81	-138.14	-167.06	-642.52
Net Profit Growth (%)	69.14	-12.87	1.89	-151.48	-214.05	-796.05
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.81	0.82	1.16	1.29	4.88	--
Close Price ($)	0.42	0.68	5.13	12.94	38.44	--
High Price ($)	1.05	7.24	13.78	48.31	48.96	--
Low Price ($)	0.40	0.64	3.17	12.74	18.15	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.19	0.16	0.13	0.02	-0.23
Short term debt to equity ratio	--	0.07	0.06	0.06	0.02	-0.06
Current Ratio	22.63	6.61	9.99	6.69	29.39	13.98
Quick Ratio	--	--	9.99	6.69	29.43	--
Interest Coverage	--	--	-58.03	-179.13	--	--

Operating Efficiency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	339.39
Asset Turnover	--	--	--	--	--	0.00
Receivable days	--	--	--	--	--	954.08
Inventory Days	--	-144.08	-14.74	-81.75	-2,251.54	--
Payable days	--	4,480.74	809.17	1,524.44	3,985.23	--
Cash Conversion Cycle	--	--	--	--	--	--